These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 18230964)

  • 1. Absence of JAK2 exon 12 mutation in acute leukemias.
    Jeong EG; Kim SH; Kim MS; Lee SH; Yoo NJ
    Acta Haematol; 2008; 119(1):38-9. PubMed ID: 18230964
    [No Abstract]   [Full Text] [Related]  

  • 2. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
    Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
    Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel JAK2 exon 12 mutation identified in the retrospective analysis of paraffin-embedded tissues of polycythemia vera patients.
    Burjanivova T; Marcinek J; Lasabova Z; Minarik G; Szepe P; Balharek T; Vanochova A; Polacek H; Plank L
    Diagn Mol Pathol; 2009 Jun; 18(2):108-11. PubMed ID: 19430293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MPL mutation profile in JAK2 mutation-negative patients with myeloproliferative disorders.
    Ma W; Zhang X; Wang X; Zhang Z; Yeh CH; Uyeji J; Albitar M
    Diagn Mol Pathol; 2011 Mar; 20(1):34-9. PubMed ID: 21326037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in exon 12 of JAK2 are mainly found in JAK2 V617F-negative polycythaemia vera patients.
    Kouroupi E; Zoi K; Parquet N; Zoi C; Kiladjian JJ; Grigoraki V; Vainchenker W; Lellouche F; Marzac C; Schlageter MH; Dosquet C; Scott LM; Fenaux P; Loukopoulos D; Chomienne C; Cassinat B
    Br J Haematol; 2008 Aug; 142(4):676-9. PubMed ID: 18503583
    [No Abstract]   [Full Text] [Related]  

  • 6. JAK2 mutations other than V617F: a novel mutation and mini review.
    Karow A; Waller C; Reimann C; Niemeyer CM; Kratz CP
    Leuk Res; 2008 Feb; 32(2):365-6. PubMed ID: 17466371
    [No Abstract]   [Full Text] [Related]  

  • 7. The JAK2 exon 12 mutations: a comprehensive review.
    Scott LM
    Am J Hematol; 2011 Aug; 86(8):668-76. PubMed ID: 21674578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The investigation of JAK2 V617F point mutation in myeloproliferative disorders by allele-specific polymerase chain reaction in combination with sequence analysis].
    Zhang SJ; Li WD; Song JH; Xu W; Qiu HX; Li JY
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(30):2109-12. PubMed ID: 17988529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JAK2-V617F mutation in cerebral venous thrombosis.
    Koopman K; Mulder AB; De Keyser J; Luijckx GJ; van der Meer J
    J Thromb Haemost; 2009 Jun; 7(6):1039-40. PubMed ID: 19344365
    [No Abstract]   [Full Text] [Related]  

  • 10. A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11) in a patient with acute myeloid leukemia.
    Cirmena G; Aliano S; Fugazza G; Bruzzone R; Garuti A; Bocciardi R; Bacigalupo A; Ravazzolo R; Ballestrero A; Sessarego M
    Cancer Genet Cytogenet; 2008 Jun; 183(2):105-8. PubMed ID: 18503828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of the JAK2 intramolecular auto-inhibition mechanism is predicted by structural modelling of a novel exon 12 insertion mutation in a case of idiopathic erythrocytosis.
    Albiero E; Madeo D; Ruggeri M; Bernardi M; Giorgetti A; Rodeghiero F
    Br J Haematol; 2008 Sep; 142(6):986-90. PubMed ID: 18671703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel SSBP2-JAK2 fusion gene resulting from a t(5;9)(q14.1;p24.1) in pre-B acute lymphocytic leukemia.
    Poitras JL; Dal Cin P; Aster JC; Deangelo DJ; Morton CC
    Genes Chromosomes Cancer; 2008 Oct; 47(10):884-9. PubMed ID: 18618714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exhaustive analysis of the P53 gene coding sequence by denaturing gradient gel electrophoresis: application to the detection of point mutations in acute leukemias.
    Pignon JM; Vinatier I; Fanen P; Jonveaux P; Tournilhac O; Imbert M; Rochant H; Goossens M
    Hum Mutat; 1994; 3(2):126-32. PubMed ID: 8199593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of the JAK2-V617F mutation in Taiwanese patients with chronic myeloproliferative disorders.
    Lieu CH; Wu HS; Hon YC; Tsai WH; Yang CF; Wang CC; Lin YC; Shih CH; Hsu HC
    Intern Med J; 2008 Jun; 38(6):422-6. PubMed ID: 18336541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fast and reliable mutation detection of the complete exon 11-15 JAK2 coding region using non-isotopic RNase cleavage assay (NIRCA).
    Kambas K; Mitroulis I; Kourtzelis I; Chrysanthopoulou A; Speletas M; Ritis K
    Eur J Haematol; 2009 Sep; 83(3):215-9. PubMed ID: 19500139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a quantitative real-time polymerase chain reaction assay for the detection of the JAK2 V617F mutation.
    Wolstencroft EC; Hanlon K; Harries LW; Standen GR; Sternberg A; Ellard S
    J Mol Diagn; 2007 Feb; 9(1):42-6. PubMed ID: 17251334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and clinical features of the JAK2 V617F mutation in pediatric patients with sporadic essential thrombocythemia.
    Nakatani T; Imamura T; Ishida H; Wakaizumi K; Yamamoto T; Otabe O; Ishigami T; Adachi S; Morimoto A
    Pediatr Blood Cancer; 2008 Dec; 51(6):802-5. PubMed ID: 18802948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The analysis of JAK2 and MPL mutations and JAK2 single nucleotide polymorphisms in MPN patients by MassARRAY assay.
    Zhang SJ; Qiu HX; Li JY; Shi JY; Xu W
    Int J Lab Hematol; 2010 Aug; 32(4):381-6. PubMed ID: 20331763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of FLT3 and JAK2 (V617F) mutations in Langerhans cell histiocytosis.
    Abedalthagafi M; Guo H; Hartmann DP; Ozdemirli M
    Leuk Res; 2009 Sep; 33(9):e173-4. PubMed ID: 19395028
    [No Abstract]   [Full Text] [Related]  

  • 20. JAK2 mutation and atypical chronic myeloid leukemia.
    Campiotti L; Uccella S; Appio L; Pallotti F; La Rosa S; Capella C; Venco A
    Leuk Res; 2009 Sep; 33(9):e166-7. PubMed ID: 19427035
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.